Showing results (511-520 of 772) with videos related to
Sort By:
Pageof 78
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|October 2, 2012
Differential presence of Papillomavirus variants in cervical cancer: an analysis for HPV33, HPV45 and HPV58J M Godínez, Daniëlle A M Heideman, T Gheit, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2013
Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trialsM M Rietbergen, R H Brakenhoff, E Bloemena, et al.International Journal of Cancer|January 11, 2021
DNA methylation markers for cancer risk prediction of vulvar intraepithelial neoplasiaNikki B Thuijs, Johannes Berkhof, Müjde Özer, et al.Optics Express|September 15, 2015
On-chip visible-to-infrared supercontinuum generation with more than 495 THz spectral bandwidthJörn P Epping, Tim Hellwig, Marcel Hoekman, et al.Human Gene Therapy|October 25, 2002
Selective gene transfer into primary human gastric tumors using epithelial cell adhesion molecule-targeted adenoviral vectors with ablated native tropismDaniëlle A M Heideman, Victor W van Beusechem, G Johan A Offerhaus, et al.BMC Women'S Health|April 28, 2018
Evaluation of human-papillomavirus testing and visual inspection for cervical cancer screening in RwandaM Chantal Umulisa, Silvia Franceschi, Iacopo Baussano, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinomaDaniëlle A M Heideman, Tim Waterboer, Michael Pawlita, et al.Medical Oncology (Northwood, London, England)|December 17, 2002
Selection of chemotherapy by ex vivo assessment of tumor sensitivity to cytotoxic drugs: results of a clinical trialAke Berglund, Bengt Glimelius, Jonas Bergh, et al.Molecular Oncology|February 13, 2021
DNA methylation markers have universal prognostic value for anal cancer risk in HIV-negative and HIV-positive individualsRamon P van der Zee, Carel J M van Noesel, Ivonne Martin, et al.Cancer Chemotherapy and Pharmacology|May 13, 1999
Interpatient variability in bioavailability of the intravenous formulation of topotecan given orally to children with recurrent solid tumorsW C Zamboni, L C Bowman, M Tan, et al.Pageof 78